<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8806785</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4226</journal-id>
<journal-id journal-id-type="nlm-ta">Glia</journal-id>
<journal-id journal-id-type="iso-abbrev">Glia</journal-id>
<journal-title-group>
<journal-title>Glia</journal-title>
</journal-title-group>
<issn pub-type="ppub">0894-1491</issn>
<issn pub-type="epub">1098-1136</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29733459</article-id>
<article-id pub-id-type="pmc">6185750</article-id>
<article-id pub-id-type="doi">10.1002/glia.23447</article-id>
<article-id pub-id-type="manuscript">NIHMS959295</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Miller</surname>
<given-names>Douglas</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shaerzadeh</surname>
<given-names>Fatemeh</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Phan</surname>
<given-names>Leah</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sharif</surname>
<given-names>Nesrin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gamble-George</surname>
<given-names>Joyonna</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McLaughlin</surname>
<given-names>Jay</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Streit</surname>
<given-names>Wolfgang J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khoshbouei</surname>
<given-names>Habibeh</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Neuroscience, University of Florida College of Medicine and McKnight Brain Institute, Gainesville, FL 32610</aff>
<aff id="A2">
<label>2</label>Department of Pharmacodynamics, University of Florida College of Pharmacy, Gainesville, FL 32610</aff>
<author-notes>
<corresp id="FN1">Authors for correspondence: Habibeh Khoshbouei, Pharm D., Ph.D., Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL 32610, <email>habibeh@ufl.edu</email>, Tel.: 352-273-8115. Wolfgang J. Streit, Ph.D., Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL 32610, <email>streit@mbi.ufl.edu</email>, Tel: 352-273-5096</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2019</year>
</pub-date>
<volume>66</volume>
<issue>9</issue>
<fpage>1915</fpage>
<lpage>1928</lpage>
<!--elocation-id from pubmed: 10.1002/glia.23447-->
<abstract id="Abs1">
<p id="P1">The transactivator of transcription protein, HIV-1 Tat, is linked to neuroAIDS, where degeneration of dopamine neurons occurs. Using a mouse model expressing GFAP-driven Tat protein under doxycycline (Dox) regulation, we investigated microglial-neuronal interactions in the rostral substantia nigra pars compacta (SNc). Immunohistochemistry for microglia and tyrosine hydroxylase (TH) showed that the ratio of microglia to dopamine neurons is smaller in the SNc than in the ventral tegmental area (VTA) and that this difference is maintained following 7-day Dox exposure in wild type animals. Administration of Dox to wild types had no effect on microglial densities. In addressing the sensitivity of neurons to potentially adverse effects of HIV-1 Tat, we found that HIV-1 Tat exposure <italic>in vivo</italic> selectively decreased TH immunoreactivity in the SNc but not in the VTA, while levels of TH mRNA in the SNc remained unchanged. HIV-1 Tat induction <italic>in vivo</italic> did not alter the total number of neurons in these brain regions. Application of Tat (5 ng) into dopamine neurons with whole-cell patch pipette decreased spontaneous firing activity. Tat induction also produced a decline in microglial cell numbers, but no microglial activation. Thus, disappearance of dopaminergic phenotype is due to a loss of TH immunoreactivity rather than to neuronal death, which would have triggered microglial activation. We conclude that adverse effects of HIV-1 Tat produce a hypodopamine state by decreasing TH immunoreactivity and firing activity of dopamine neurons. Reduced microglial numbers after Tat exposure <italic>in vivo</italic> suggest impaired microglial functions and altered bidirectional interactions between dopamine neurons and microglia.</p>
</abstract>
<abstract abstract-type="graphical" id="Abs2">
<title>Graphical Abstract</title>
<p id="P2">
<graphic orientation="portrait" position="anchor" xlink:href="nihms959295u1.jpg"></graphic></p>
</abstract>
<kwd-group>
<kwd>neuroAIDS</kwd>
<kwd>microglia</kwd>
<kwd>dopamine neurons</kwd>
<kwd>HIV-1 Tat</kwd>
<kwd>microglia-neuron interactions</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>